News
Kerassentials is a meticulously formulated toenail infection treatment solution that targets more problematic issues, such as ...
ImmunoPrecise Antibodies Ltd. (IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSaitm ...
A pop-up overdose prevention tent is now running once a week in downtown St. John's. Overdose Awareness and Response St.
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
The U.S. Patent and Trademark Office (USPTO) held a “USPTO Hour” Wednesday in which it announced the results of a study it ...
The government’s Strong Borders Act would let Canada Post and police open mail, create powers to cancel immigration en masse and more ...
As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.
New drug application submission was based on positive data from the Phase III GLISTEN trial, which demonstrated significant ...
Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...
Genetic screening technology now allows parents employing in vitro fertilization (IVF) to select for certain traits, allowing ...
Markets ended lower on Tuesday, weighed down by IT, financials, and other rate-sensitive stocks. Investor sentiment remained ...
As previously announced, the FDA also granted iopofosine I 131 Fast Track Designation and Orphan Drug Designation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results